Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin to maintain benzodiazepine-free status after alprazolam in generalized anxiety disorder
2006-001347-66Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in generalized anxiety disorder (GAD) comparing Pregabalin arm with Placebo arm (2 arms). Primary endpoint: Benzodiazepine- and psychoactive drug-free status during alprazolam-free phase. Started Jul 2006; status: completed.
02
Drugs
pregabalin
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on 2006-001347-66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001347-66.